X

pharmaceuticals

Strong pipeline, M&A synergies to keep Bristol Myers on growth path

Bristol Myers Squibb Company (NYSE: BMY) is thriving on its multi-pronged growth plan, based on strategic acquisitions and the promising…

Bristol Myers (BMY) stock gains after Q4 results beat Street view

Bristol-Myers Squibb Company (NYSE: BMY) Thursday reported stronger-than-expected fourth-quarter results. The company's stock gained in the pre-market session soon after…

Infographic: Highlights of Merck & Co. (MRK)Q4 2020 earnings report

Merck & Co., Inc. (NYSE: MRK) reported weak earnings and sales for the fourth quarter of 2020. Worldwide sales edged…

AbbVie (ABBV) Earnings: 4Q20 Key Numbers

AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today. Worldwide net revenues rose 59.2% year-over-year to $13.8 billion…

Pfizer (PFE) Q4 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its fourth quarter 2020 earnings results today. Revenues increased 12% year-over-year to $11.7 billion. On…

Infographic: Vertex Pharmaceuticals (VRTX) 4Q20 Earnings Results

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported fourth quarter 2020 earnings results today. Total revenues increased 15% year-over-year to $1.62 billion.…

Where do these companies stand in the COVID-19 vaccine race?

After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19…

Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals

Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate.…

Fate Therapeutics (FATE) looks headed for a turnaround post-COVID

Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market's attention after reporting positive results from…

Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health

Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth…

Johnson & Johnson (JNJ) beats market estimates in Q4

Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant…

Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates

Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical…

COVID-related medical costs may weigh on UnitedHealth’s performance this year

The health insurance sector has been facing multiple challenges from the virus crisis, but market-leading healthcare firm UnitedHealth Group (NYSE:…

Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%

Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab…

Codexis (CDXS) may be moving closer to profitability, after beating slowdown

Biosciences company Codexis, Inc. (NASDAQ: CDXS) has emerged stronger from a rough patch, supported mainly by the resilience of its…

Covid vaccine won’t dent Ampio Pharma’s market: CEO Michael Macaluso

Since its foundation in 2008, Ampio Pharmaceuticals (NYSE: AMPE) has been focused on delivering a drug that treats inflammation caused…

Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch

Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the…

Rite Aid (RAD) looks to regain lost ground with new rebound strategy

Rite Aid Corporation (NYSE: RAD) is on a mission to put the house in order and achieve sustainable profitability, after…

Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary

Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug…

COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge

Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one…

Rite Aid Corporation (RAD) Q3 2021 Earnings Call Transcript

Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse -- Senior Vice President, Investor…